GlassScriptPhysician profile
Mary Henderson James
NPI 1538320924
$4,193.06
in general payments reported to CMS, 2019-2025
32 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $926 · 2020: $75.62 · 2021: $61.64 · 2022: $282 · 2023: $730 · 2024: $1,005 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,813 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,812.83 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,069.63 | 2019-2025 | |
| Axonics, INC. | $677.93 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $307.09 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $255.91 | 2019-2023 | Veozah |
| Medtronic, INC. | $202.15 | 2022-2025 | Interstim |
| Abbvie INC. | $194.00 | 2023-2025 | |
| Caldera Medical, INC | $176.90 | 2023-2025 | Desara |
| Boston Scientific Corporation | $172.14 | 2019-2025 | Rezum Generator |
| Endo USA, INC. | $137.64 | 2024-2025 | Xiaflex, Aveed |
| Allergan, INC. | $125.65 | 2019-2022 | |
| Endo Pharmaceuticals INC. | $109.71 | 2019-2024 | Xiaflex |
| Merck Sharp & Dohme LLC | $75.05 | 2024-2025 | Keytruda, Zerbaxa |
| Sun Pharmaceutical Industries INC. | $63.79 | 2023-2024 | Yonsa |
| Ferring Pharmaceuticals INC. | $62.67 | 2024-2025 | Adstiladrin |
| Calyxo, INC. | $54.85 | 2024 | Cvac Aspiration System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $47.28 | 2024-2025 | |
| Blue Earth Diagnostics | $46.02 | 2019-2025 | Posluma |
| Urovant Sciences INC | $41.58 | 2022 | |
| Laborie Medical Technologies Corp. | $41.37 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $39.12 | 2023 | Jelmyto |
| Janssen Biotech, INC. | $38.63 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Procept Biorobotics Corporation | $30.26 | 2025 | |
| Pfizer INC. | $29.93 | 2024 | |
| Tolmar, INC. | $29.85 | 2025 | Jatenzo, Eligard |
| Profound Medical Corp. | $23.56 | 2025 | Tulsa-Pro |
| C. R. Bard, INC. & Subsidiaries | $21.67 | 2025 | Bard Urinary Drainage Bag |
| Accord Healthcare, INC. | $19.98 | 2025 | |
| Dendreon Pharmaceuticals LLC | $18.92 | 2024 | Provenge |
| Mission Pharmacal Company | $16.82 | 2020 | |
| Abc Home Medical Supply, INC. | $14.02 | 2024 | |
| Photocure INC | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary James listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.